Radiation Therapy Not Found To Increase Lymphedema Risk in Node-Negative Breast Cancer, According To Patient-Reported Data

Radiation Therapy Not Found To Increase Lymphedema Risk in Node-Negative Breast Cancer, According To Patient-Reported Data
LymphedemaDuring the American Society for Radiation Oncology’s (ASTRO’s) 56th Annual Meeting at the Moscone Center in San Francisco, September 14-17, 2014, a study entitled “The Impact of Radiation Therapy on Lymphedema Risk and the Agreement Between Subjective and Objective Lymphedema Measures: NSABP B-32 Secondary Data Analysis,” was presented, showing that radiation therapy (RT) does not increase the incidence of lymphedema in patients with node-negative breast cancer. This study was conducted by Susan McCloskey, MD, MSHS, assistant professor of radiation oncology at The David Geffen School of Medicine at University of California, Los Angeles. ASTRO’s 56th Annual Meeting is the nation’s leading scientific meeting in radiation oncology and is expected to attract more than 11,000 attendees from a wide group of disciplines, from medical physicists to practice administrators, industry representatives, and other health care professionals from around the world. This year's annual meeting's theme is “Targeting Cancer: Technology and Biology.” The Presidential Symposium, “Local-regional Management of Breast Cancer: A Changing Paradigm,” is being led by ASTRO President Bruce G. Haffty, MD, FASTRO, a radiation oncologist specializing in breast cancer, and Jay R. Harris, MD, FASTRO, and Thomas A. Buchholz, MD, FASTRO. During the ASTRO’s four-day scientific meeting, three keynote speakers will address a range of topics including o
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.